Our Science
Cutting-edge research and technology
Make history
Develop your career at PMI
Smoke-Free Life
Go beyond your past, make a positive change
pmi-emblem

Why invest in PMI?

We've built the world’s most successful cigarette company. Now we’re building our future on smoke-free products that are much better choices.

$ 7102

0.54 (0.77%)

Investor Relations

Latest News & Press Releases

Media Center
  • News 26 Oct, 2020

    PMI announces Medicago to supply up to 76 million doses of its plant-derived COVID-19 vaccine candidate

  • Press Release 23 Oct, 2020

    PMI Announces Medicago to Supply Up to 76 Million Doses of Its Plant-Derived COVID-19 Vaccine Candidate

  • News 21 Oct, 2020

    Lasting effects: How COVID-19 is changing illicit trade

  • Press Release 20 Oct, 2020

    Philip Morris International Inc. Reports 2020 Third-Quarter Reported Diluted EPS of $1.48 Versus $1.22 in 2019, Reflecting Adjusted Diluted EPS Growth of 5.6% on an Organic Basis

This site is operated for the purpose of providing general information about us. The site is not operated for advertising or marketing purposes. The material on this site should not be regarded as an offer to sell, or a solicitation of an offer to buy, any product of PMI. Such products are sold only in compliance with the laws of the particular jurisdictions in which they are sold.